Read articles from Global

November 18, 2025 by regulatorwatch.com

GOOD COP 2.0 | Day 2 of 5 | RegWatch (Live)

DAY #2 | Live from Geneva, Switzerland – RegWatch special coverage of the Taxpayers Protection Alliance’s Good COP 2.0, the tobacco harm reduction counter-conference to the World Health Organization’s COP 11.

November 18, 2025 by regulatorwatch.com

GOOD COP 2.0 | Day 2 of 5 | RegWatch (Live)

DAY #2 | Live from Geneva, Switzerland – RegWatch special coverage of the Taxpayers Protection Alliance’s Good COP 2.0, the tobacco harm reduction counter-conference to the World Health Organization’s COP 11.

November 17, 2025 by manilatimes.net

Ex-WHO officials call for global tobacco control reset to save millions

Former WHO officials have called on governments to revamp global tobacco control strategies, warning that ignoring tobacco harm reduction (THR) could cost millions of lives. In a new report, Tikki Pang, Derek Yach, Chris Snowdon, and Peter Beckett argued that the Framework Convention on Tobacco Control (FCTC) needs a “reset” to include safer nicotine products like e-cigarettes, heated tobacco devices, and oral nicotine pouches. They emphasized that broader access to these lower-risk alternatives could sharply reduce smoking-related deaths, especially in low- and middle-income countries with high cigarette consumption.

November 17, 2025 by regulatorwatch.com

GOOD COP 2.0 | Day 1 of 5 | RegWatch (Live)

Live from Geneva, Switzerland – RegWatch brings you exclusive coverage of the Taxpayers Protection Alliance’s Good COP 2.0, a tobacco harm reduction counter-conference held alongside the WHO’s COP 11. Good COP 2.0 gathers 37 experts from 22 countries to distinguish facts from myths and challenge the misinformation influencing global health policy.

November 17, 2025 by regulatorwatch.com

It's excellent, thank you. I'm sharing this on NSP

Live from Geneva, Switzerland – RegWatch brings you exclusive coverage of the Taxpayers Protection Alliance’s Good COP 2.0, a tobacco harm reduction counter-conference held alongside the WHO’s COP 11. Good COP 2.0 gathers 37 experts from 22 countries to distinguish facts from myths and challenge the misinformation influencing global health policy.

November 14, 2025 by substack.com

WHO position on harm reduction : enough is enough

The WHO recently released a paper on tobacco control and harm reduction before the FCTC COP-11. It discusses harm reduction in tobacco and nicotine products, refuting claims that non-combustible products are as harmful as cigarettes and criticizing the WHO's stance on harm reduction as aligned with the tobacco industry. The document calls for prohibition and restrictive measures against these products, ignoring their potential role in reducing harm from smoking. These recommendations may inadvertently protect the cigarette market, contradicting the WHO's objectives. It emphasizes the need for a balanced approach to tobacco control.

November 14, 2025 by regulatorwatch.com

Hostile WHO | Exclusionary Tactics Threaten Tobacco Harm Reduction | RegWatch

As the WHO’s Framework Convention on Tobacco Control (FCTC) prepares for COP11 in Geneva, its track record of silencing dissent and bending evidence to demonize safer nicotine products stands exposed. Through tortured data, selective science, and an absolutist anti-nicotine agenda bankrolled by billionaire donors, the FCTC has shifted from a treaty against smoking to a template for exclusionary global health governance—one that ignores evidence, excludes dissenting experts, and punishes nations that embrace harm reduction. Joining RegWatch to dissect this threat is Dr. Roger Bate, PhD economist, international health policy researcher, and nonresident scholar at the International Center for Law and Economics. Dr. Bate explains how WHO’s hostility to market-driven alternatives isn’t just misguided—it’s dangerous.

November 14, 2025 by regulatorwatch.com

Hostile WHO | Exclusionary Tactics Threaten Tobacco Harm Reduction | RegWatch

As the WHO’s Framework Convention on Tobacco Control (FCTC) prepares for COP11 in Geneva, its track record of silencing dissent and bending evidence to demonize safer nicotine products stands exposed. Through tortured data, selective science, and an absolutist anti-nicotine agenda bankrolled by billionaire donors, the FCTC has shifted from a treaty against smoking to a template for exclusionary global health governance—one that ignores evidence, excludes dissenting experts, and punishes nations that embrace harm reduction. Joining RegWatch to dissect this threat is Dr. Roger Bate, PhD economist, international health policy researcher, and nonresident scholar at the International Center for Law and Economics. Dr. Bate explains how WHO’s hostility to market-driven alternatives isn’t just misguided—it’s dangerous.

November 14, 2025 by regulatorwatch.com

Hostile WHO | Exclusionary Tactics Threaten Tobacco Harm Reduction | RegWatch

As the WHO’s Framework Convention on Tobacco Control (FCTC) prepares for COP11 in Geneva, its track record of silencing dissent and bending evidence to demonize safer nicotine products stands exposed. Through tortured data, selective science, and an absolutist anti-nicotine agenda bankrolled by billionaire donors, the FCTC has shifted from a treaty against smoking to a template for exclusionary global health governance—one that ignores evidence, excludes dissenting experts, and punishes nations that embrace harm reduction. Joining RegWatch to dissect this threat is Dr. Roger Bate, PhD economist, international health policy researcher, and nonresident scholar at the International Center for Law and Economics. Dr. Bate explains how WHO’s hostility to market-driven alternatives isn’t just misguided—it’s dangerous.

November 14, 2025 by filtermag.org

Grassroots Harm Reduction Sidelined in NY Opioid Fund Spending

Alexis Pleus shared how her son's opioid addiction journey began with a knee injury and prescribed medication, leading to addiction and tragic consequences. She founded Truth Pharm for harm reduction advocacy after losing her sons to overdose. Despite effective community outreach, small organizations like hers lack funding, with major portions going to large hospitals. New York's $3 billion Opioid Settlement Fund mostly supports big institutions, sidelining local groups. The Drug Policy Alliance calls for equitable distribution to combat overdose fatalities, highlighting discriminations faced by those with substance use disorders. Pleus emphasizes the vital role of grassroots groups in filling gaps left by larger systems.